Vasquez et al v. AstraZeneca Pharmaceuticals LP et al
Plaintiff: Deborah Vasquez and Guadalupe Vasquez
Defendant: AstraZeneca Pharmaceuticals LP and Bristol-Myers Squibb Company
Case Number: 5:2018cv00569
Filed: October 10, 2018
Court: US District Court for the Eastern District of Kentucky
Presiding Judge: Karen K Caldwell
Nature of Suit: Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability
Cause of Action: 28 U.S.C. § 1332
Jury Demanded By: Plaintiff
Docket Report

This docket was last retrieved on December 6, 2018. A more recent docket listing may be available from PACER.

Date Filed Document Text
December 6, 2018 Opinion or Order Filing 11 ORDER REGARDING MANDATORY CM/ECF REGISTRATION FOR COUNSEL OF RECORD: The following attorneys (Dylan James Hooper and Eric Holland), who have failed to register with the CM-ECF system as required, SHALL RETURN to the Court an Electronic Filing Attorney Registration Form within 14 days from the entry date of this order. Failure to do so may result in sanctions being imposed by the Court, including termination of the right to practice before this Court. Signed by Judge Karen K. Caldwell on 12/6/2018.Associated Cases: 5:18-md-02809-KKC et al.(CBD)cc: COR w/ copy of MDL 2809 ECF Ref. Form to Dylan J. Hooper and Eric Holland
November 28, 2018 ***MOTION SUBMITTED TO CHAMBERS of Judge Caldwell for review: re MOTION for Entry of Case Management Order Establishing Standards & Procedures for Counsel Seeking Reimbursement for Common Benefit Fees & Costs (180 in 5:18-md-02809-KKC, et al) Associated Cases: 5:18-md-02809-KKC et al.(TDA)
November 19, 2018 Filing 10 MASTER COMPLAINT AND JURY DEMAND, filed by Plaintiffs David Taylor, et al against Defendants Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals, LP, and McKesson Corporation. Filed per QC re 184 in 5:18-md-2809, et alAssociated Cases: 5:18-md-02809-KKC et al.(CBD)
November 19, 2018 Filing 9 AMENDED DOCUMENT by David Taylor, Leatha Taylor. Plaintiffs' Master Complaint and Jury Demand. Associated Cases: 5:18-md-02809-KKC et al.(Moore, Jennifer)See DE ( 185 in 5:18-md-2809) for CORRECTED entry of this pleading Modified on 11/21/2018 (CBD).
November 19, 2018 Filing 8 JOINT MOTION FOR ENTRY OF STIPULATED CASE MANAGEMENT ORDER by Plaintiffs, Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP, and McKesson Corporation (Attachments: #1 Exhibit 1-Proposed Stipulated CMO, #2 Exhibit 2- Plaintiff Profile Form and Authorization)Associated Cases: 5:18-md-02809-KKC et al.(Moore, Jennifer) Modified text on 11/20/2018 (CBD).
November 6, 2018 Filing 7 MOTION for Entry by David Taylor of Case Management Order Establishing Standards & Procedures for Counsel Seeking Reimbursement for Common Benefit Fees & Costs (Attachments: #1 Proposed Order, #2 PO Exhibit A, #3 PO Exhibit B, #4 PO Exhibit C) Associated Cases: 5:18-md-02809-KKC et al.(Moore, Jennifer) Modified text on 11/9/2018 (TDA).
October 24, 2018 Opinion or Order Filing 6 CASE MANAGEMENT ORDER NO. 1 REGARDING MASTER PLEADINGS AND PROPOSED DISCOVERY PLAN FOR PHASE ONE: GENERAL CAUSATION: plaintiffs' proposal (DE 168 in 5:18-md-2809, et al) to conduct concurrent discovery on all issues is DENIED. The Court further ORDERS as follows: 1. Both parties having proposed the filing of a Master Complaint, the Court hereby ORDERS that, on or before November 19, 2018, Plaintiffs must file a Master Complaint. 2. The Master Complaint may not be amended absent leave of the Court. 3. The Master Complaint will be the operative complaint in every individual action for the duration of these pretrial proceedings except that Defendants may respond to any individual complaint by way of motions permissible under Rule 12 of the FRCP. 4. If the parties wish to utilize Plaintiff Fact Sheets, authorization forms, and/or Defendant Fact Sheets, they must file proposed facts sheets and authorization forms and an accompanying motion for approval on or before November 19, 2018. If the parties are unable to agree on such fact sheets and forms, they may file separate proposals. Any objections to the motion for approval must be filed within 14 days of the date the motion for approval is filed. 5. On or before December 19, 2018, Defendants must file a Master Answer ("Master Answer") responding to the allegations of the Master Complaint. 6. Defendants will be deemed to have answered all cases pending in, filed in, or subsequently transferred to the MDL proceedings upon the filing of the Master Answer. The Master Answer will be deemed to deny any allegations contained in individual complaints that are not contained in the Master Complaint. 7. After the filing of the Master Answer, cases may only be voluntarily dismissed by order of the Court pursuant to Federal Rule of Civil Procedure 41(a)(2) or a stipulation pursuant to Federal Rule of Civil Procedure 41(a)(1)(ii), except that a Complaint filed directly in the MDL may be voluntarily dismissed upon notice by Plaintiff within ten (10) days of the filing of the Complaint. 8. Neither the filing of the Master Answer, nor the filing of a Notice of Appearance, nor CM/ECF registration, nor the appearance of any party or counsel at a status conference constitutes a waiver of any defense including lack of personal jurisdiction, objections to service, jurisdiction or venue, and any defenses to any state law claims. 9. The plaintiffs may not file a reply to the Master Answer. 10. Both parties having proposed the use of a Short Form Complaint, no later than December 19, 2018, Plaintiffs counsel must file a proposed Short Form Complaint and accompanying motion for approval stating the Short Form Complaint's proposed purpose and effect. Any objections to the motion for approval must be filed within 14 days of the date the motion for approval is filed. 11. On or before January 15, 2019, the parties must file a proposed plan. 12. In any action that is (a) filed in or transferred to this Court after this Order is entered and (b) consolidated with this action for pretrial purposes, the Clerk need not separately file the Case Management Orders already entered in these MDL proceedings. However, the Clerk must include a statement in the initial notice to counsel that the Order Regarding Practice and Procedure Upon Transfer, this Case Management Order, and all subsequent Case Management Orders govern all cases in the MDL proceedings. Signed by Judge Karen K. Caldwell on 10/24/2018. Associated Cases: 5:18-md-02809-KKC et al.(CBD)cc: COR Modified text on 10/24/2018 (CBD).
October 11, 2018 REMARK: Counsel shall refer to #www.kyed.uscourts.gov/518-md-02809-kkc for review of Orders relative to filing procedures in MDL 2809. If you are not registered as an ECF Filing User, please complete the ECF Registration Form and return it to the Clerk within twenty-one (21) days. cc: Order Regarding Practice & Procedure upon Transfer filed February 9, 2018 served via U.S. Mail to counsel not registered as ECF Filing Users. (CBD)
October 11, 2018 Conflict Check run. (CBD)
October 10, 2018 Filing 4 CASE TRANSFERRED IN from District of New Jersey. Case number 3:18-cv-13461. Original file, certified copy of transfer order and docket sheet received electronically. cc: COR Modified on 10/11/2018 (CBD).
October 10, 2018 Opinion or Order Filing 3 Order of MDL Panel transferring case to the USDC for the KYED. (dm ) [Transferred from njd on 10/11/2018.]
September 4, 2018 Filing 2 SUMMONS ISSUED as to ASTRAZENECA PHARMACEUTICALS, LP, BRISTOL MYERS SQUIBB AND COMPANY. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jem) [Transferred from njd on 10/11/2018.]
August 31, 2018 Filing 1 COMPLAINT against ASTRAZENECA PHARMACEUTICALS LP, BRISTOL MYERS SQUIBB AND COMPANY ( Filing and Admin fee $ 400 receipt number 0312-8994621) with JURY DEMAND, filed by DEBORAH VASQUEZ, GUADALUPE VASQUEZ. (Attachments: #1 Certificate of Service, #2 Civil Cover Sheet)(SACKS, SHAYNA) [Transferred from njd on 10/11/2018.]
August 31, 2018 Judge Michael A. Shipp and Magistrate Judge Tonianne J. Bongiovanni added. (mem, ) [Transferred from njd on 10/11/2018.]

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Kentucky Eastern District Court's Electronic Court Filings (ECF) System

Search for this case: Vasquez et al v. AstraZeneca Pharmaceuticals LP et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: AstraZeneca Pharmaceuticals LP
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Bristol-Myers Squibb Company
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Deborah Vasquez
Represented By: Jennifer A. Moore
Represented By: Shayna E. Sacks
Represented By: Laraclay Drake Parker
Represented By: Timothy Michael Clark
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Guadalupe Vasquez
Represented By: Jennifer A. Moore
Represented By: Shayna E. Sacks
Represented By: Laraclay Drake Parker
Represented By: Timothy Michael Clark
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?